Human alpha1-proteinase inhibitor for treating emphysema (terminated appraisal) (TA965)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 March 2024
Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 25 April 2024
Digital supported self-management technologies for adults with chronic obstructive pulmonary disease: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 15 August 2024
Dupilumab for treating moderate to severe chronic obstructive pulmonary disease [ID6235]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Bronchoscopic intrabullous autologous blood instillation (BIABI) for the therapy of Emphysema: intractable with pneumothorax, COPD & Lung cancer, patients requiring lung biopsyStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Virtual Wards for COPD exacerbationsStatus:Awaiting developmentProgramme:Medical technologies guidanceExpected publication date: TBC